申请人:X4 Pharmaceuticals, Inc.
公开号:US20210009557A1
公开(公告)日:2021-01-14
The present invention relates to compounds and methods useful for modulation, e.g. inhibition, of C-X-C receptor type 4 (CXCR4). The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using the compositions in the treatment of various disorders.